NEW YORK (GenomeWeb) – BioDiscovery announced today that it has signed a collaborative agreement to provide its NxClinical data visualization software to Illumina.

Under the terms of the agreement, NxClinical will be the secondary data analysis and management tool for Illumina's CytoSeq assay. The software will be offered as an interactive tool for visualization and interpretation of genomic events, the firms said, and will directly read CytoSeq results to process data and provide results.

Financial and other details were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.